arrow
Back
S

Stefan D. Anker

german centre for cardiovascular research

162H-index
1.2KPaper Count
14.2WCitation Count
Published Papers 705
Publication Date
Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy
err2026-10-07
err0
PREAI
errSara Hadzibegovic; Jonathan L. Hella; Jan Porthun; Alessia Lena; Danara Krug; Iulia Baluta; Ursula Wilkenshoff; Amir A. Mahabadi; Matthias Totzeck; Tienush Rassaf; Stefan D. Anker; Wolfram Doehner; Ulrich Keller; Lars Bullinger; Dominik P. Modest; Barry J. A. Laird; Richard J. E. Skipworth; John G. F. Cleland; Christian Oeing; Stephan von Haehling; Ulf Landmesser; Markus S. Anker
errShare
errSave
Iron deficiency and bone metabolism in heart failure
err2026-08-19
err0
PREAI
errRyosuke Sato; Tania Garfias-Veitl; Angelika Hafke; Andreas Fischer; Guglielmo Fibbi; Mirela Vatic; Breno Wozne; Constanze Schmidt; Jürgen Kolos; Max Diesner; Thomas Bernd Dschietzig; Goran Loncar; John G F Cleland; Stefan D Anker; Stephan von Haehling⁠
errShare
errSave
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis
err2026-08-18
err0
errOAAI
errMihály Ruppert; Muthiah Vaduganathan; Brian L Claggett; Akshay S Desai; Pardeep S Jhund; Alasdair Henderson; James Lay-Flurrie; Meike Brinker; Lucas Hofmeister; Markus S Anker; Carolyn S P Lam; Michele Senni; Sanjiv J Shah; Adriaan A Voors; Faiez Zannad; Peter Rossing; Luis M Ruilope; Bertram Pitt; Rajiv Agarwal; John J V McMurray; Scott D Solomon; Stefan D Anker; Gerasimos Filippatos
errShare
errSave
Impact of Empagliflozin on Serum Calcium and Phosphate in Heart Failure
err2026-08-07
err0
PREAI
errJOÃO PEDRO FERREIRA; FAIEZ ZANNAD; GERASIMOS FILIPPATOS; PEDRO MARQUES; FRANCISCO VASQUES-NÓVOA; JOÃO SÉRGIO NEVES; LUIS MENDONÇA; JAVED BUTLER; STEFAN D. ANKER; MILTON PACKER
errShare
errSave
Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status
err2026-07-30
err0
PREAI
errFrederick Lu; Amiya A Ahmed; Sijian Zhang; Venkatesh K Raman; Samir S Patel; Jose D Vargas; Gregg C Fonarow; Paul A Heidenreich; John G F Cleland; Stefan D Anker; Michael Böhm; Marco Metra; Michael R Zile; Deepak L Bhatt; Tariq Ahmad; Phillip H Lam; Hans J Moore; Charles Faselis; Charity J Morgan; Helen M Sheriff; Qing Zeng-Treitler; Wen-Chih Wu; Ali Ahmed⁠
errShare
errSave
errShare
errSave
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
err2026-04-24
err0
errOAAI
errJoão Sérgio Neves; Ana Rita Leite; Francisco Vasques-Nóvoa; Bertram Pitt; Gerasimos Filippatos; Luis M. Ruilope; Peter Rossing; Stefan D. Anker; Gianluigi Savarese; Charlie A. B. Scott; Andrea Lage; Meike D. Brinker; João Pedro Ferreira
errShare
errSave
Lifetime benefits of finerenone on cardiorenal morbidity and mortality in chronic kidney disease and type 2 diabetes: a pooled analysis of FIDELIO-DKD and FIGARO-DKD trials
err2026-04-07
err0
PREAI
errJohn W Ostrominski; Brendon L Neuen; Brian L Claggett; Rajiv Agarwal; Gerasimos Filippatos; Peter Rossing; Luis M Ruilope; Bertram Pitt; Meike Brinker; Andrea Lage; Patrick Schloemer; Katja Rohwedder; John J V McMurray; Scott D Solomon; Muthiah Vaduganathan; Stefan D Anker
errShare
errSave
The EMPATICC-trial-should location shape therapy?
err2026-01-01
err0
PREAI
errAnker, Markus S.; Anker, Stefan D.; Rassaf, Tienush
errShare
errSave
Criteria Adrift
err2025-12-01
err0
PREAI
errStephan von Haehling; Constanze Schmidt; Stefan D. Anker
errShare
errSave
A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD
err2025-11-28
err0
errOAAI
errAjay K. Singh; Stefan D. Anker; Bertram Pitt; Peter Rossing; Luis M. Ruilope; Christiane Ahlers; Youssef M.K. Farag; Marc Lambelet; Meike D. Brinker; Katja Rohwedder; Gerasimos Filippatos
errShare
errSave
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes
errJACC
IF0
err2025-11-18
err0
errOAAI
errJohn W. Ostrominski; Brendon L. Neuen; Brian L. Claggett; Gerasimos Filippatos; Akshay S. Desai; Pardeep S. Jhund; Alasdair Henderson; Carolyn S.P. Lam; Michele Senni; Sanjiv J. Shah; Adriaan A. Voors; Faiez Zannad; Peter Rossing; Luis M. Ruilope; Stefan D. Anker; Bertram Pitt; Rajiv Agarwal; James Lay-Flurrie; Meike Brinker; Flaviana Amarante
errShare
errSave
Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials
err2025-11-10
err0
errOAAI
errJoão Pedro Ferreira PhD; Pedro Marques MD; Stefan D. Anker PhD; Javed Butler MD; Gerasimos Filippatos PhD; Abhinav Sharma PhD; Francisco Vasques-Nóvoa MD; Luís Mendonça PhD; João Sérgio Neves PhD; Milton Packer MD; Faiez Zannad PhD
errShare
errSave
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations
err2025-10-01
err0
errOAAI
errHeerspink, Hiddo J. L.; Agarwal, Rajiv; Amor, Antonio J.; Bech, Jesper N.; Cherney, David Z., I; Fiorina, Paolo; Rossing, Peter; Schousboe, Karoline; Selby, Nicholas M.; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Lawatscheck, Robert; Brinker, Meike; Russell, Julie; Schloemer, Patrick; Mcgill, Janet B.
errShare
errSave
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI
err2025-09-19
err0
errOAAI
errMarco Metra; Daniela Tomasoni; Marianna Adamo; Offer Amir; Stefan D. Anker; Antoni Bayes-Genis; Michael Boehm; Javed Butler; Ovidiu Chioncel; Gerasimos Filippatos; Finn Gustafsson; Ewa A. Jankowska; Juan Carlos Kaski; Brenda Moura; Mark C. Petrie; Piotr Ponikowski; Amina Rakisheva; Arsen Ristic; Francois Roubille; Gianluigi Savarese; Petar Seferovic; Peter van der Meer; Maurizio Volterrani; Andrew J. Coats; Vijay K. Chopra; Giuseppe Rosano
errShare
errSave
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI
err2025-09-14
err0
errOAAI
errFrancesco Fioretti; Javed Butler; Jacob A. Udell; W. Schuyler Jones; Mark C. Petrie; Josephine Harrington; Michaela Mattheus; Johann Bauersachs; Antoni Bayes-Genis; Shaun G. Goodman; Tomasz Gasior; James L. Januzzi; Renato D. Lopes; Piotr Ponikowski; Xavier Rossello; Morten Schou; Peter van der Meer; Dragos Vinereanu; Shelley Zieroth; Martina Brueckmann; Mikhail Sumin; Deepak L. Bhatt; Adrian F. Hernandez; Stefan D. Anker
errShare
errSave
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)
err2025-08-30
err0
errOAAI
errMarkus S Anker; Amir A Mahabadi; Matthias Totzeck; Mitra Tewes; Muhammad Shahzeb Khan; Raluca I Mincu; Ulrike B Hendgen-Cotta; Lars Michel; Baicy Mathew; Ophelia Drescher; Martin Schuler; Ulrich Keller; Kathrin Rieger; Johann Ahn; Lars Bullinger; Dominik P Modest; Corinna Denecke; Lucie Kretzler; Luisa V Ramer; Danara Krug; Ulf Landmesser; Lorenz H Lehmann; Norbert Frey; Sven Bercker; Ulrich Laufs; Michael Böhm; Felix Mahfoud; Bela Merkely; Monika Diek; Javed Butler; Anja Veiser; Tim Heise; Martin Hellmich; Marius Placzek; Tim Friede; Stefan D Anker; Tienush Rassaf; null
errShare
errSave
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials
errJACC
IF0
err2025-08-27
err0
errOAAI
errJohn W. Ostrominski; Josephine Harrington; Brian L. Claggett; Gerasimos Filippatos; Akshay S. Desai; Pardeep S. Jhund; Alasdair D. Henderson; Carolyn S.P. Lam; Michele Senni; Sanjiv J. Shah; Adriaan A. Voors; Faiez Zannad; Peter Rossing; Luis M. Ruilope; Stefan D. Anker; Bertram Pitt; Rajiv Agarwal; Meike D. Brinker; Katja Rohwedder; James Lay-Flurrie; Andrea Lage; John J.V. McMurray; Scott D. Solomon; Muthiah Vaduganathan
errShare
errSave